Institute for Diabetes, Obesity and Metabolism
Announcement: 2022 Pilot and Feasibility Grant Awards. See Grant Programs below for more.
The Institute for Diabetes, Obesity and Metabolism at the University of Minnesota is uniquely poised to become a premier research institute that is focused on advancing knowledge of the pathophysiology of diabetes and its complications through cutting edge research.
The mission of the Institute for Diabetes, Obesity and Metabolism (IDOM) is to enhance research quality by growing multidisciplinary collaborations in diabetes research by creating a rich environment that unites diabetes investigators through enrichment and training opportunities, to provide access to pilot funds, and to make cost-effective animal physiology services available to members of the IDOM. Our goal is to create the environment and infrastructure necessary to support funded diabetes investigators and the integration of their data into our greater understanding of the whole of diabetes.
We are committed to creating a research environment that supports fundamental projects designed to understand the basic biology of the disease and then translating these findings to humans. This commitment will ensure that our basic findings are relevant to the human model and support of the development of new ways to prevent and treat the disease and its complications.
Pilot and Feasibility
2022 Collaborative Iowa-Minnesota Pilot and Feasibility Grant is awarded to Drs. Ashutosh Mangalam, Hans-Joachim Lehmler, and Christina Camell for their project entitled "Environmental toxicant glyphosate synergizes with Western diet to induced obesity by increasing the gut microbial dysbiosis and adipose tissue inflammation”.
2022 University of Minnesota Institute for Diabetes, Obesity and Metabolism Pilot and Feasibility Grants were awarded to Dr. Alessandro Bartolomucci for his project entitled "Neuron-microglia communication mediated by the neuropeptide TLQP-21 and the Complement 3a Receptor 1: role in energy balance and obesity" and Dr. Amir Moheet for his project entitled "Efficacy and safety of SGLT2 inhibitor empagliflozin therapy in overweight and obese subjects with cystic fibrosis-related diabetes: a pilot study
The Institute for Diabetes, Obesity and Metabolism is pleased to announce that Dr. Lisa Chow, from the Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, along with Co-PI, Dr. Rui Zhang, from the Institute for Health Informatics and the Department of Pharmaceutical Care & Health Systems, are awarded $50,000 for FY22. Their project: "Use of a Mobile Food Record, Enhanced by a Novel Artificial Intelligence-Based Informatics Framework, to Expand Capture of Dietary Intake" Congratulations to our 2021 UMN/UI Collaborative Pilot & Feasibility (P&F) Grant Award Recipients!
The first cycle of the IDOM P&F program was recently completed.
David Bernlohr from BMBB was awarded $50,000 for each of the next two years to complete the work described in his application, “Adipose Senescence and Type 2 Diabetes".
Doug Mashek, from BMBB and the Department of Medicine, along with Eric Taylor from the Department of Molecular Physiology and Biophysics at the University of Iowa were recipients of the collaborative award designed to support work lead by investigators at both UMN and UI. Their project, “Defining the role of lipid droplet-mitochondria interactions in spatiotemporal regulation of energy metabolism”, will be performed with the support of $100,000 funds over two years from the IDOM and $100,000 over two years from FOEDRC at the UI.
IDOM Equipment Fund
IDOM will consider requests to provide funds for the purchase of new multi-user equipment that will be utilized by two or more members of IDOM. The limit for IDOM supported equipment purchases is $10,000 but in unique circumstances greater levels of support may be considered. Request to provide funds to support service contracts of existing equipment are discouraged. Applications will be reviewed by the IDOM Executive Committee on a rolling basis and generally be completed within 3 weeks of receipt of application. For more information,
Individuals applying for membership should submit a current CV and a cover letter to firstname.lastname@example.org with the subject IDOM membership request. The cover letter should include:
- Why the investigator wants to join the Institute for Diabetes, Obesity and Metabolism
- What expertise and research interests he/she brings, and
- An idea of the collaboration or research in which he/she would like to engage
In existence since 1977, the post-doctoral training program in diabetes, endocrinology, and metabolism at the University of Minnesota has prepared MDs and PhDs for successful research careers in academic medicine. This preparation has centered upon the critical interaction between the trainee and the research mentor.
All mentors in this program have national or international reputations in their respective areas and have strong track records in mentoring. Our faculty have expertise in cellular metabolism and genetics; endocrinology and signaling; neurobiology and appetite regulation of obesity; stem cell biology, autoimmunity, and β-cell biology; and clinical aspects of endocrine disease.
Trainees enter the program after they have either completed a residency program in internal medicine or received a PhD in a biological science at a major research University. Graduates of the program are established at Universities and research institutions worldwide.